Cell Line : YMB-1-E
Cellosaurus Index : CVCL_2815
Cellosaurus ID : YMB-1-E
CCLE Name
: YMB1E_BREAST
GDSC1 Name
, GDSC2 Name
: YMB-1-E
Cancer Type : breast
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| YMB-1-E | 5-Fluorouracil | GDSC1,GDSC2 | 0.0200 | 32.0000 |
|
| YMB-1-E | A-83-01 | GDSC1 | 0.0200 | 5.1200 |
|
| YMB-1-E | ABT737 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | ACY-1215 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | Afatinib | GDSC2 | 0.0040 | 4.0000 |
|
| YMB-1-E | Afuresertib | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | AGI-5198 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | AGI-6780 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| YMB-1-E | AGK-2 | GDSC2 | 0.0040 | 4.0000 |
|
| YMB-1-E | AKT inhibitor VIII | GDSC1 | 0.0400 | 10.2400 |
|
| YMB-1-E | Alectinib | GDSC1 | 0.0200 | 5.1200 |
|
| YMB-1-E | Alisertib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Alpelisib | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | AMG-319 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Amuvatinib | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | Apitolisib | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | AR-42 | GDSC1 | 0.0200 | 5.1200 |
|
| YMB-1-E | Ara-G | GDSC1 | 0.0200 | 5.1200 |
|
| YMB-1-E | ARRY-520 | GDSC1 | 0.0010 | 0.2560 |
|
| YMB-1-E | AS605240 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | AST-1306 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | AT-7519 | GDSC1 | 0.0400 | 10.2400 |
|
| YMB-1-E | AT13148 | GDSC2 | 0.0080 | 8.0000 |
|
| YMB-1-E | AT7867 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | Avagacestat | GDSC1,GDSC2 | 0.0100 | 10.2400 |
|
| YMB-1-E | Axitinib | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | AZ6102 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | AZ960 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | AZD3759 | GDSC2 | 0.0010 | 1.0000 |
|
| YMB-1-E | AZD4547 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | AZD5363 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | AZD5582 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | AZD6482 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | AZD6738 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | AZD7762 | GDSC2 | 0.0010 | 2.0000 |
|
| YMB-1-E | AZD8186 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | BAM7 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | Belinostat | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | BI-2536 | GDSC2 | 0.0005 | 0.5000 |
|
| YMB-1-E | BIBF-1120 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | BIBR-1532 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Bicalutamide | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | BIX02189 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | BMS-345541 | GDSC1,GDSC2 | 0.0100 | 16.0000 |
|
| YMB-1-E | BMS-536924 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | BMS-754807 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Bortezomib | GDSC2 | 0.0000 | 0.0200 |
|
| YMB-1-E | Bosutinib | GDSC2 | 0.0020 | 2.0000 |
|
| YMB-1-E | Brivanib, BMS-540215 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | Buparlisib | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | BX-912 | GDSC1 | 0.0400 | 10.2400 |
|
| YMB-1-E | BX795 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | C-75 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | Cabozantinib | GDSC1 | 0.0200 | 5.1200 |
|
| YMB-1-E | Camptothecin | GDSC2 | 0.0001 | 0.1000 |
|
| YMB-1-E | CAP-232, TT-232, TLN-232 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | CAY10566 | GDSC1 | 0.0100 | 2.5600 |
|
| YMB-1-E | CAY10603 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | CCT-018159 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | CCT007093 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | CD532 | GDSC1 | 0.0200 | 5.1200 |
|
| YMB-1-E | Cediranib | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | CHIR-99021 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | CI-1033 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | CP466722 | GDSC1 | 0.0625 | 16.0000 |
|
| YMB-1-E | CP724714 | GDSC1 | 0.0400 | 10.2400 |
|
| YMB-1-E | CPI-613 | GDSC1 | 1.0000 | 256.0000 |
|
| YMB-1-E | Crizotinib | GDSC2 | 0.0040 | 8.0000 |
|
| YMB-1-E | CUDC-101 | GDSC1 | 0.0200 | 5.1200 |
|
| YMB-1-E | CX-5461 | GDSC1 | 0.0400 | 10.2400 |
|
| YMB-1-E | Cyclophosphamide | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | CZC24832 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Dabrafenib | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Dactinomycin | GDSC2 | 0.0008 | 0.8000 |
|
| YMB-1-E | Dactolisib | GDSC2 | 0.0003 | 0.2500 |
|
| YMB-1-E | Daporinad | GDSC2 | 0.0010 | 1.0000 |
|
| YMB-1-E | Dasatinib | GDSC2 | 0.0020 | 2.0000 |
|
| YMB-1-E | Dinaciclib | GDSC2 | 0.0010 | 1.0000 |
|
| YMB-1-E | Docetaxel | GDSC2 | 0.0000 | 0.0125 |
|
| YMB-1-E | Doramapimod | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | eEF2K Inhibitor, A-484954 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | EHT-1864 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Elesclomol | GDSC2 | 0.0002 | 0.2000 |
|
| YMB-1-E | Entinostat | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Entospletinib | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Enzastaurin | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | Epirubicin | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | EPZ004777 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | EPZ5676 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Erlotinib | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | ETP-45835 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | Fedratinib | GDSC1 | 0.0400 | 10.2400 |
|
| YMB-1-E | Flavopiridol | GDSC1 | 0.0100 | 2.5600 |
|
| YMB-1-E | FMK | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | Foretinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | FR-180204 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | FTY-720 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | Fulvestrant | GDSC2 | 0.0010 | 1.0000 |
|
| YMB-1-E | GDC0810 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Gefitinib | GDSC2 | 0.0020 | 2.0000 |
|
| YMB-1-E | Gemcitabine | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Genentech Cpd 10 | GDSC1 | 0.0400 | 10.2400 |
|
| YMB-1-E | GNE-317 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | GSK1059615 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | GSK1070916 | GDSC1 | 0.0100 | 2.5600 |
|
| YMB-1-E | GSK1904529A | GDSC2 | 0.0050 | 5.0000 |
|
| YMB-1-E | GSK2578215A | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | GSK2606414 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | GSK269962A | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | GSK343 | GDSC2 | 0.0010 | 1.0000 |
|
| YMB-1-E | GSK429286A | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | GSK591 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | GSK690693 | GDSC1 | 0.0400 | 10.2400 |
|
| YMB-1-E | GW-2580 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | GW441756 | GDSC2 | 0.0020 | 2.0000 |
|
| YMB-1-E | I-BET-762 | GDSC1,GDSC2 | 0.0100 | 20.0000 |
|
| YMB-1-E | I-BRD9 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Ibrutinib | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | IC-87114 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | Idelalisib | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | IMD-0354 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | IOX2 | GDSC2 | 0.0005 | 0.5000 |
|
| YMB-1-E | Ipatasertib | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Irinotecan | GDSC2 | 0.0050 | 5.0000 |
|
| YMB-1-E | Ispinesib Mesylate | GDSC1 | 0.0005 | 0.1280 |
|
| YMB-1-E | IWP-2 | GDSC2 | 0.0010 | 1.0000 |
|
| YMB-1-E | JNJ38877605 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | JNK Inhibitor VIII | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | JQ1 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | JW-7-24-1 | GDSC1 | 0.0400 | 10.2400 |
|
| YMB-1-E | kb NB 142-70 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | KIN001-042 | GDSC1 | 0.0400 | 10.2400 |
|
| YMB-1-E | KIN001-236 | GDSC1 | 0.0400 | 10.2400 |
|
| YMB-1-E | KIN001-244 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | KIN001-260 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | KIN001-266 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | KIN001-270 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | Kobe2602 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | KRAS (G12C) Inhibitor-12 | GDSC2 | 0.0200 | 20.0000 |
|
| YMB-1-E | KU-55933 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Lapatinib | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | LCL161 | GDSC1,GDSC2 | 0.0100 | 20.0000 |
|
| YMB-1-E | LDN-193189 | GDSC1 | 0.0400 | 10.2400 |
|
| YMB-1-E | Leflunomide | GDSC2 | 0.1001 | 100.0000 |
|
| YMB-1-E | Lenalidomide | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Lestaurtinib | GDSC2 | 0.0020 | 2.0000 |
|
| YMB-1-E | LGK974 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| YMB-1-E | LIMK1 inhibitor BMS4 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | Linifanib | GDSC1 | 0.0040 | 1.0240 |
|
| YMB-1-E | Linsitinib | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | LJI308 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Luminespib | GDSC2 | 0.0003 | 0.2500 |
|
| YMB-1-E | LY2109761 | GDSC2 | 0.0050 | 5.0000 |
|
| YMB-1-E | Masitinib | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | MetAP2 Inhibitor, A832234 | GDSC1 | 0.0100 | 2.5600 |
|
| YMB-1-E | Methotrexate | GDSC2 | 0.0010 | 1.0000 |
|
| YMB-1-E | MG-132 | GDSC2 | 0.0040 | 4.0000 |
|
| YMB-1-E | MIM1 | GDSC1 | 0.1562 | 40.0000 |
|
| YMB-1-E | MIRA-1 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Mirin | GDSC2 | 0.1001 | 100.0000 |
|
| YMB-1-E | MK-1775 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | MK-2206 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | MK-8776 | GDSC2 | 0.0050 | 5.0000 |
|
| YMB-1-E | ML323 | GDSC2 | 0.0200 | 20.0000 |
|
| YMB-1-E | MN-64 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Motesanib | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | MPS-1-IN-1 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | Navitoclax | GDSC2 | 0.0020 | 2.0000 |
|
| YMB-1-E | NG-25 | GDSC1 | 0.0400 | 10.2400 |
|
| YMB-1-E | Nilotinib | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Niraparib | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | NPK76-II-72-1 | GDSC1 | 0.0400 | 10.2400 |
|
| YMB-1-E | NSC-207895 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | NSC319726 | GDSC1 | 0.0040 | 1.0240 |
|
| YMB-1-E | NU7441 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Nutlin-3a | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | NVP-ADW742 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | NVP-BHG712 | GDSC1 | 0.0400 | 10.2400 |
|
| YMB-1-E | OF-1 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Olaparib | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Omipalisib | GDSC1 | 0.0005 | 0.1280 |
|
| YMB-1-E | OSI-027 | GDSC1,GDSC2 | 0.0100 | 20.0000 |
|
| YMB-1-E | OSI-930 | GDSC1 | 0.0400 | 10.2400 |
|
| YMB-1-E | Osimertinib | GDSC2 | 0.0010 | 1.0000 |
|
| YMB-1-E | OTX015 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Oxaliplatin | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | P22077 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Paclitaxel | GDSC2 | 0.0001 | 0.1000 |
|
| YMB-1-E | Palbociclib | GDSC2 | 0.0040 | 4.0000 |
|
| YMB-1-E | Panobinostat | GDSC1 | 0.0040 | 1.0240 |
|
| YMB-1-E | PCI-34051 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | PD0325901 | GDSC2 | 0.0025 | 2.5000 |
|
| YMB-1-E | PD173074 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Pelitinib | GDSC1 | 0.0098 | 2.5000 |
|
| YMB-1-E | Pemetrexed | GDSC1 | 0.0400 | 10.2400 |
|
| YMB-1-E | Pevonedistat | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | PF-00299804 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | PF-4708671 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | PFI-1 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | PFI3 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | PHA-793887 | GDSC1 | 0.0400 | 10.2400 |
|
| YMB-1-E | Phenformin | GDSC1 | 15.6250 | 4000.0000 |
|
| YMB-1-E | PI-103 | GDSC1 | 0.0400 | 10.2400 |
|
| YMB-1-E | Picolinici-acid | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Pictilisib | GDSC2 | 0.0040 | 4.0000 |
|
| YMB-1-E | PIK-93 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | Pilaralisib | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | Piperlongumine | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | PLX-4720 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | PRIMA-1MET | GDSC2 | 0.0300 | 30.0000 |
|
| YMB-1-E | PRT062607 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Pyridostatin | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | QL-X-138 | GDSC1 | 0.0400 | 10.2400 |
|
| YMB-1-E | QL-XI-92 | GDSC1 | 0.0400 | 10.2400 |
|
| YMB-1-E | QL-XII-47 | GDSC1 | 0.0400 | 10.2400 |
|
| YMB-1-E | Quizartinib | GDSC1 | 0.0040 | 1.0240 |
|
| YMB-1-E | Rapamycin | GDSC2 | 0.0001 | 0.1000 |
|
| YMB-1-E | Refametinib | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Ribociclib | GDSC2 | 0.0020 | 2.0000 |
|
| YMB-1-E | RO-3306 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | RU-SKI 43 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | Rucaparib | GDSC2 | 0.0050 | 5.0000 |
|
| YMB-1-E | Ruxolitinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | RVX-208 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Sabutoclax | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Sapitinib | GDSC2 | 0.0050 | 5.0000 |
|
| YMB-1-E | Savolitinib | GDSC2 | 0.0010 | 1.0000 |
|
| YMB-1-E | SB216763 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | SB505124 | GDSC1,GDSC2 | 0.0100 | 20.0000 |
|
| YMB-1-E | SB52334 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | SB590885 | GDSC2 | 0.0050 | 5.0000 |
|
| YMB-1-E | SCH772984 | GDSC2 | 0.0050 | 5.0000 |
|
| YMB-1-E | Selisistat | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | Selumetinib | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Sepantronium bromide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Serdemetan | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | SGC0946 | GDSC2 | 0.0005 | 0.5000 |
|
| YMB-1-E | SL0101 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | SN-38 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | SNX-2112 | GDSC1 | 0.0100 | 2.5600 |
|
| YMB-1-E | Sorafenib | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Sphingosine Kinase 1 Inhibitor II | GDSC1 | 0.0100 | 2.5600 |
|
| YMB-1-E | Staurosporine | GDSC2 | 0.0078 | 2.0000 |
|
| YMB-1-E | STF-62247 | GDSC1 | 0.0400 | 10.2400 |
|
| YMB-1-E | SU11274 | GDSC1 | 0.0400 | 10.2400 |
|
| YMB-1-E | T0901317 | GDSC1 | 0.0400 | 10.2400 |
|
| YMB-1-E | TAK-715 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | Talazoparib | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Tamoxifen | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Tanespimycin | GDSC2 | 0.0010 | 1.0000 |
|
| YMB-1-E | Taselisib | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Telomerase Inhibitor IX | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Temozolomide | GDSC2 | 0.0300 | 30.0000 |
|
| YMB-1-E | Temsirolimus | GDSC2 | 0.0010 | 1.0000 |
|
| YMB-1-E | Tenovin-6 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | THZ-2-102-1 | GDSC1 | 0.0098 | 2.5000 |
|
| YMB-1-E | THZ-2-49 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | Tivozanib | GDSC1 | 0.0005 | 0.1280 |
|
| YMB-1-E | TL-1-85 | GDSC1 | 0.0400 | 10.2400 |
|
| YMB-1-E | TL-2-105 | GDSC1 | 0.0400 | 10.2400 |
|
| YMB-1-E | Torin 2 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | Tozasertib | GDSC2 | 0.0050 | 5.0000 |
|
| YMB-1-E | TPCA-1 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | Trametinib | GDSC2 | 0.0010 | 1.0000 |
|
| YMB-1-E | Tretinoin | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Trichostatin A | GDSC1 | 0.0040 | 1.0240 |
|
| YMB-1-E | Tubastatin A | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | TWS119 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | Ulixertinib | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | UNC0638 | GDSC1 | 0.1562 | 40.0000 |
|
| YMB-1-E | Uprosertib | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | VE-822 | GDSC2 | 0.0050 | 5.0000 |
|
| YMB-1-E | VE821 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Veliparib | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Venetoclax | GDSC2 | 0.0010 | 1.0000 |
|
| YMB-1-E | Venotoclax | GDSC1 | 0.0010 | 0.2560 |
|
| YMB-1-E | Vinorelbine | GDSC2 | 0.0001 | 0.1000 |
|
| YMB-1-E | Vismodegib | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | VNLG-124 | GDSC1 | 0.0200 | 5.1200 |
|
| YMB-1-E | Vorinostat | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Voxtalisib | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | VX-11e | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Wee1 Inhibitor | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | WEHI-539 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | WHI-P97 | GDSC1 | 0.0400 | 10.2400 |
|
| YMB-1-E | WIKI4 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | Wnt-C59 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| YMB-1-E | WYE-125132 | GDSC1 | 0.0400 | 10.2400 |
|
| YMB-1-E | WZ3105 | GDSC1 | 0.0050 | 1.2800 |
|
| YMB-1-E | WZ4003 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | XAV939 | GDSC2 | 0.0050 | 5.0000 |
|
| YMB-1-E | XMD13-2 | GDSC1 | 0.0400 | 10.2400 |
|
| YMB-1-E | XMD14-99 | GDSC1 | 0.0400 | 10.2400 |
|
| YMB-1-E | XMD15-27 | GDSC1 | 0.0400 | 10.2400 |
|
| YMB-1-E | Y-39983 | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | YK-4-279 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | YM201636 | GDSC1 | 0.0200 | 5.1200 |
|
| YMB-1-E | Zibotentan | GDSC1 | 0.0781 | 20.0000 |
|
| YMB-1-E | ZM447439 | GDSC2 | 0.0100 | 10.0000 |
|
| YMB-1-E | ZSTK474 | GDSC1 | 0.0200 | 5.1200 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC